Overdiagnosis and overtreatment: Beware of guidelines with expanded disease definition

Research output: Chapter in Book/Report/Conference proceedingOther chapter contributionResearchpeer-review

Abstract

Along with other aspirations, shared decision making (SDM) has the laudable aim of bringing more scrutiny of evidence into our health care choices, including assessing the risks and benefits of all treatment options. But as evidence about the problem of ‘overdiagnosis’ grows, we may need to bring more attention to the risks and benefits of a diagnostic label, even before any scrutiny of the pros and cons of possible treatments. This chapter explores how heavily conflicted guideline panels are expanding disease definitions, labelling those with milder symptoms or at lower risks, for whom a diagnosis and treatment may do more harm than good. It explores several examples where there is controversy over recently widened definitions. The chapter concludes that if we’re to better inform people about the risks of overdiagnosis and related overtreatment, and ultimately assist in reducing them, genuine SDM will include information about controversies over disease definitions.

Original languageEnglish
Title of host publicationShared decision making in health care
Subtitle of host publicationAchieving evidence-based patient choice
EditorsG Elwyn, A Edwards, R Thompson
PublisherOxford University Press
Pages129-134
Number of pages6
ISBN (Print)9780198723448
DOIs
Publication statusPublished - 2016

Fingerprint

Guidelines
Decision Making
Therapeutics
Delivery of Health Care
Medical Overuse
Aspirations (Psychology)

Cite this

Moynihan, R. N. (2016). Overdiagnosis and overtreatment: Beware of guidelines with expanded disease definition. In G. Elwyn, A. Edwards, & R. Thompson (Eds.), Shared decision making in health care: Achieving evidence-based patient choice (pp. 129-134). Oxford University Press. https://doi.org/10.1093/acprof:oso/9780198723448.003.0020
Moynihan, Ray N. / Overdiagnosis and overtreatment : Beware of guidelines with expanded disease definition. Shared decision making in health care: Achieving evidence-based patient choice. editor / G Elwyn ; A Edwards ; R Thompson. Oxford University Press, 2016. pp. 129-134
@inbook{31a9380a3cdc48a49c2a3ac6273df493,
title = "Overdiagnosis and overtreatment: Beware of guidelines with expanded disease definition",
abstract = "Along with other aspirations, shared decision making (SDM) has the laudable aim of bringing more scrutiny of evidence into our health care choices, including assessing the risks and benefits of all treatment options. But as evidence about the problem of ‘overdiagnosis’ grows, we may need to bring more attention to the risks and benefits of a diagnostic label, even before any scrutiny of the pros and cons of possible treatments. This chapter explores how heavily conflicted guideline panels are expanding disease definitions, labelling those with milder symptoms or at lower risks, for whom a diagnosis and treatment may do more harm than good. It explores several examples where there is controversy over recently widened definitions. The chapter concludes that if we’re to better inform people about the risks of overdiagnosis and related overtreatment, and ultimately assist in reducing them, genuine SDM will include information about controversies over disease definitions.",
author = "Moynihan, {Ray N}",
year = "2016",
doi = "10.1093/acprof:oso/9780198723448.003.0020",
language = "English",
isbn = "9780198723448",
pages = "129--134",
editor = "G Elwyn and A Edwards and R Thompson",
booktitle = "Shared decision making in health care",
publisher = "Oxford University Press",
address = "United Kingdom",

}

Moynihan, RN 2016, Overdiagnosis and overtreatment: Beware of guidelines with expanded disease definition. in G Elwyn, A Edwards & R Thompson (eds), Shared decision making in health care: Achieving evidence-based patient choice. Oxford University Press, pp. 129-134. https://doi.org/10.1093/acprof:oso/9780198723448.003.0020

Overdiagnosis and overtreatment : Beware of guidelines with expanded disease definition. / Moynihan, Ray N.

Shared decision making in health care: Achieving evidence-based patient choice. ed. / G Elwyn; A Edwards; R Thompson. Oxford University Press, 2016. p. 129-134.

Research output: Chapter in Book/Report/Conference proceedingOther chapter contributionResearchpeer-review

TY - CHAP

T1 - Overdiagnosis and overtreatment

T2 - Beware of guidelines with expanded disease definition

AU - Moynihan, Ray N

PY - 2016

Y1 - 2016

N2 - Along with other aspirations, shared decision making (SDM) has the laudable aim of bringing more scrutiny of evidence into our health care choices, including assessing the risks and benefits of all treatment options. But as evidence about the problem of ‘overdiagnosis’ grows, we may need to bring more attention to the risks and benefits of a diagnostic label, even before any scrutiny of the pros and cons of possible treatments. This chapter explores how heavily conflicted guideline panels are expanding disease definitions, labelling those with milder symptoms or at lower risks, for whom a diagnosis and treatment may do more harm than good. It explores several examples where there is controversy over recently widened definitions. The chapter concludes that if we’re to better inform people about the risks of overdiagnosis and related overtreatment, and ultimately assist in reducing them, genuine SDM will include information about controversies over disease definitions.

AB - Along with other aspirations, shared decision making (SDM) has the laudable aim of bringing more scrutiny of evidence into our health care choices, including assessing the risks and benefits of all treatment options. But as evidence about the problem of ‘overdiagnosis’ grows, we may need to bring more attention to the risks and benefits of a diagnostic label, even before any scrutiny of the pros and cons of possible treatments. This chapter explores how heavily conflicted guideline panels are expanding disease definitions, labelling those with milder symptoms or at lower risks, for whom a diagnosis and treatment may do more harm than good. It explores several examples where there is controversy over recently widened definitions. The chapter concludes that if we’re to better inform people about the risks of overdiagnosis and related overtreatment, and ultimately assist in reducing them, genuine SDM will include information about controversies over disease definitions.

U2 - 10.1093/acprof:oso/9780198723448.003.0020

DO - 10.1093/acprof:oso/9780198723448.003.0020

M3 - Other chapter contribution

SN - 9780198723448

SP - 129

EP - 134

BT - Shared decision making in health care

A2 - Elwyn, G

A2 - Edwards, A

A2 - Thompson, R

PB - Oxford University Press

ER -

Moynihan RN. Overdiagnosis and overtreatment: Beware of guidelines with expanded disease definition. In Elwyn G, Edwards A, Thompson R, editors, Shared decision making in health care: Achieving evidence-based patient choice. Oxford University Press. 2016. p. 129-134 https://doi.org/10.1093/acprof:oso/9780198723448.003.0020